ADMA Biologics, Inc. (ADMA)
12.78
+0.06
(+0.43%)
USD |
NASDAQ |
Nov 09, 16:00
12.78
0.00 (0.00%)
After-Hours: 17:56
ADMA Biologics Gross Profit (Annual) : 292.62M for Dec. 31, 2025
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 292.62M |
| December 31, 2024 | 219.16M |
| December 31, 2023 | 88.22M |
| December 31, 2022 | 34.55M |
| December 31, 2021 | 0.4579M |
| December 31, 2020 | -19.79M |
| December 31, 2019 | -11.00M |
| December 31, 2018 | -26.05M |
| Date | Value |
|---|---|
| December 31, 2017 | -14.14M |
| December 31, 2016 | -1.147M |
| December 31, 2015 | 2.866M |
| December 31, 2014 | -1.678M |
| December 31, 2013 | -1.374M |
| December 31, 2012 | 0.4491M |
| December 31, 2011 | -1.256M |
| December 31, 2010 | -4.070M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 971.62M |
| BioMarin Pharmaceutical, Inc. | 2.505B |
| Nektar Therapeutics | 54.21M |
| Rhythm Pharmaceuticals, Inc. | 169.83M |
| Arcutis Biotherapeutics, Inc. | 339.38M |